Acurx Pharmaceuticals Inc (ACXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,967 | -6,388 | -4,396 | -2,149 | -14,103 |
| Other Working Capital | -394 | -420 | -192 | -397 | 206 |
| Other Operating Activity | 1,572 | 1,205 | 865 | 495 | 3,514 |
| Operating Cash Flow | $-6,788 | $-5,603 | $-3,722 | $-2,052 | $-10,383 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,808 | 2,335 | 610 | N/A | N/A |
| Other Financing Activity | 6,829 | 5,468 | 5,469 | 2,989 | 6,616 |
| Financing Cash Flow | $10,637 | $7,803 | $6,080 | $2,989 | $6,616 |
| Beginning Cash Position | 3,707 | 3,707 | 3,707 | 3,707 | 7,474 |
| End Cash Position | 7,556 | 5,907 | 6,064 | 4,644 | 3,707 |
| Net Cash Flow | $3,849 | $2,200 | $2,357 | $937 | $-3,768 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,788 | -5,603 | -3,722 | -2,052 | -10,383 |
| Free Cash Flow | -6,788 | -5,603 | -3,722 | -2,052 | -10,383 |